These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 30567985)
1. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985 [TBL] [Abstract][Full Text] [Related]
2. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. Ramírez JC; Gherardi MM; Esteban M J Virol; 2000 Jan; 74(2):923-33. PubMed ID: 10623755 [TBL] [Abstract][Full Text] [Related]
3. Modified Vaccinia Virus Ankara Can Induce Optimal CD8 Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596 [TBL] [Abstract][Full Text] [Related]
4. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara. Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585 [TBL] [Abstract][Full Text] [Related]
6. Zoonotic vaccinia virus strains belonging to different genetic clades exhibit immunomodulation abilities that are proportional to their virulence. Lourenço KL; Chinália LA; Henriques LR; Rodrigues RAL; da Fonseca FG Virol J; 2021 Jun; 18(1):124. PubMed ID: 34107993 [TBL] [Abstract][Full Text] [Related]
7. Strikingly poor CD8+ T-cell immunogenicity of vaccinia virus strain MVA in BALB/c mice. Russell TA; Tscharke DC Immunol Cell Biol; 2014; 92(5):466-9. PubMed ID: 24566805 [TBL] [Abstract][Full Text] [Related]
8. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
9. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV. Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625 [TBL] [Abstract][Full Text] [Related]
10. Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice. Larsen IV; Clausius H; Kolb AW; Brandt CR J Virol; 2016 Jul; 90(14):6557-6572. PubMed ID: 27170749 [TBL] [Abstract][Full Text] [Related]
11. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector. Gómez CE; Rodríguez D; Rodríguez JR; Abaitua F; Duarte C; Esteban M Vaccine; 2001 Dec; 20(5-6):961-71. PubMed ID: 11738764 [TBL] [Abstract][Full Text] [Related]
12. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA). Abdalrhman I; Gurt I; Katz E Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280 [TBL] [Abstract][Full Text] [Related]
13. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917 [TBL] [Abstract][Full Text] [Related]
14. Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses. Hayasaka D; Ennis FA; Terajima M Virol J; 2007 Feb; 4():22. PubMed ID: 17326843 [TBL] [Abstract][Full Text] [Related]
15. Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage. Garcel A; Fauquette W; Dehouck MP; Crance JM; Favier AL Vaccine; 2012 Feb; 30(7):1397-405. PubMed ID: 22227123 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. Staib C; Kisling S; Erfle V; Sutter G J Gen Virol; 2005 Jul; 86(Pt 7):1997-2006. PubMed ID: 15958679 [TBL] [Abstract][Full Text] [Related]
17. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus. Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174 [TBL] [Abstract][Full Text] [Related]
18. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes. Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024 [TBL] [Abstract][Full Text] [Related]
19. The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity. Greiner S; Humrich JY; Thuman P; Sauter B; Schuler G; Jenne L Clin Exp Immunol; 2006 Nov; 146(2):344-53. PubMed ID: 17034588 [TBL] [Abstract][Full Text] [Related]
20. Correlations between vaccinia-specific immune responses within a cohort of armed forces members. Umlauf BJ; Ovsyannikova IG; Haralambieva IH; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA Viral Immunol; 2011 Oct; 24(5):415-20. PubMed ID: 21958369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]